Loading...
XKRX
084110
Market cap218mUSD
Oct 08, Last price  
23,100.00KRW
1D
3.01%
1Q
-9.79%
Jan 2017
-23.02%
IPO
-33.07%
Name

Huons Global Co Ltd

Chart & performance

D1W1MN
XKRX:084110 chart
P/E
9.78
P/S
0.33
EPS
2,362.59
Div yield, %
5.03%
Shrs. gr., 5y
1.16%
Rev. gr., 5y
10.13%
Revenues
847.45b
+4.18%
134,072,148,320158,182,764,740182,342,752,70065,448,158,240163,712,232,478323,960,589,100378,687,481,597449,422,998,000523,047,737,000574,647,695,000664,364,718,000758,379,661,000813,460,515,000847,453,174,000
Net income
28.84b
+11.82%
6,667,122,97017,382,520,47020,932,848,10032,384,338,35322,821,238,86825,764,228,74729,160,495,87226,657,291,00042,695,967,0003,994,541,000-60,254,135,00038,383,627,00025,791,032,00028,838,245,000
CFO
93.61b
-6.93%
18,044,646,53024,806,033,55028,792,391,07050,908,903,22919,383,639,00047,518,191,47653,574,796,36465,546,999,00090,591,630,00049,821,825,00064,373,890,00099,967,135,000100,571,082,00093,605,927,000
Dividend
Aug 28, 2026400 KRW/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Huons Global Co., Ltd., headquartered in Seongnam, South Korea, is a healthcare enterprise dedicated to delivering a wide array of medical solutions for human well-being, serving both domestic and international markets. The company manufactures and distributes an extensive portfolio of pharmaceutical products. This includes oral solid medications addressing diverse therapeutic areas such as cardiovascular health, metabolic disorders, pain and inflammation, digestive issues, respiratory conditions, infections, urogenital ailments, and general wellness. Their injectable offerings are even more comprehensive, encompassing anesthetics, analgesics, anti-inflammatory agents, muscle relaxants, hormones, enzymes, minerals, antibiotics, and treatments for metabolic, circulatory, and respiratory systems, among many other specialized applications. Beyond pharmaceuticals, Huons Global also provides medical devices, ophthalmic preparations, and biological products. Founded in 1965, the company operated as Huons Co., Ltd. until its rebranding to Huons Global Co., Ltd. in June 2016.

Key people

Gi An Uhm
Managing Director
Hyeon Suk Yoo
Managing Director · since 2012
Ho Geun Choi
Assistant Managing Director
Yin Suk Lee
Internal Auditor · since 2012
Sang Man Lee
Assistant Managing Director · since 2009
Yong Seung Lee
Assistant Managing Director
Bo Yeong Yoon
Assistant Managing Director · since 2009
Wan Seop Kim
Director · since 2020
Su Yeong Son
President, Chief Executive Officer, Director · since 2022
Jong Deok Choi
Non-Executive Independent Director · since 2012
IPO date
Dec 19, 2006
Employees
Domiciled in
KR
Incorporated in
KR

Valuation

Title
KRW in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT